George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 5,550 shares at $580.00 ($3.2M) on 2020-05-13, disclosed to the SEC on 2020-05-13.
Open-market sale of $3.2M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $575.00 | 250 | $144K | 4.5% |
| 2 | $575.00 | 300 | $173K | 5.4% |
| 3 | $580.00 | 5,000 | $2.9M | 90.2% |
| Total | $579.50 avg | 5,550 | $3.2M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |